Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Predictors of CBT Outcomes in Youth Anxiety: Integrative Data Analysis Approach
A Randomized Trial of Unruptured Brain AVMs (ARUBA)-STAT
Child Treatment in Hispanic Migrant Populations
Regulation of Macrophage Phenotypes in Lung Repair
Role of Novel PI-3 Kinase in Hematopoietic Cell Growth
Recently added grants:
AIDS-related HSV-1 retinal necrosis: Innate immunity and virus spread
Predicting Adolescent Depression Using Machine Learning
Effect of B-cell depletion on vaginal microbiota and mucosal immunity
Development of isogenic iPSC cell lines expressing tauopathy-related PERK risk variants to study homeostatic control of protein levels during ER stress
Defining a role for monocyte licensing in the regulation of Leishmania-specific T cell immunity following short- and long-term pre-exposure to sand fly blood feeding
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025140-002
Application #
6828866
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant